ADCT EBITDA Growth
Adc Therapeutics Sa · EBITDA Growth
ADCT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported24.12%period ending
ADCT TTM EBITDA YoY % (9.47% → 24.12%)
Year-over-year change
High-resolution chart · PNG
ADCT ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 24.1155% | |
| 14.0632% | |
| 14.6464% | |
| 3.6625% | |
| 4.355% | |
| 31.1439% | |
| 33.0601% | |
| 11.4976% | |
| 13.3238% | |
| 8.8635% | |
| -33.7749% | |
| 11.1553% | |
| 20.1138% | |
| 18.0589% | |
| 49.553% | |
| 36.469% | |
| 7.6909% | |
| 23.4056% | |
| 4.4061% | |
| -6.6452% | |
| 19.0722% | |
| -86.841% | |
| -111.1018% | |
| -101.6403% | |
| -112.5274% | |
| -10.5887% | |
| 9.466% |